Physician profile
Richard Khalil
NPI 1912011107
$93,856.34
in general payments reported to CMS, 2019-2025
97 companies · $11K in 2025
The $11K reported for 2025 was more than what 99% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $15K · 2021: $19K · 2022: $15K · 2023: $12K · 2024: $9,870 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $31K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,788 · Education: $594.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $30,557.36 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,787.50 |
| Education | $593.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $19,631.26 | 2019-2025 | |
| Allergan, INC. | $8,642.14 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $8,179.23 | 2019-2025 | Tezspire, Farxiga, Airsupra |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $5,893.98 | 2019-2025 | Xifaxan, Trulance, Relistor |
| Novo Nordisk INC | $3,952.93 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $2,932.74 | 2019-2025 | Jardiance, Stiolto Respimat, Spiriva Respimat |
| Glaxosmithkline, LLC. | $2,690.13 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Amgen INC. | $2,522.56 | 2019-2025 | Evenity, Repatha, Prolia |
| Otsuka America Pharmaceutical, INC. | $2,213.08 | 2019-2025 | Rexulti, Abilify Maintena, Abilify Asimtufii |
| Astellas Pharma US INC | $2,068.19 | 2019-2025 | Veozah, Myrbetriq |
| Sanofi-Aventis U.S. LLC | $1,944.85 | 2019-2025 | |
| Lilly USA, LLC | $1,881.14 | 2019-2025 | Mounjaro, Zepbound, Emgality |
| Teva Pharmaceuticals USA, INC. | $1,809.08 | 2019-2023 | Austedo Xr |
| Daiichi Sankyo INC. | $1,767.03 | 2019-2023 | Injectafer |
| Genzyme Corporation | $1,700.66 | 2021-2025 |
Show all 97 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $1,460.89 | 2019-2022 | |
| Lundbeck LLC | $1,047.42 | 2021-2025 | Rexulti, Vyepti |
| Esperion Therapeutics, INC. | $1,043.04 | 2020-2025 | Nexletol |
| Axsome Therapeutics, INC. | $962.77 | 2024-2025 | Auvelity, Symbravo |
| Novartis Pharmaceuticals Corporation | $946.19 | 2019-2024 | |
| Antares Pharma, INC. | $923.45 | 2019-2025 | Xyosted, Nocdurna, Tlando |
| Merck Sharp & Dohme LLC | $891.48 | 2019-2025 | Verquvo, Dificid, Belsomra |
| Ardelyx, INC. | $856.58 | 2022-2025 | Ibsrela |
| Abbott Laboratories | $848.63 | 2020-2025 | Freestyle Libre 3, Jeti Peripheral Catheter |
| Ironwood Pharmaceuticals, INC | $827.55 | 2019-2024 | Linzess |
| Amarin Pharma, INC. | $795.10 | 2019-2023 | |
| Cmp Pharma, INC. | $770.50 | 2020-2023 | Carospir, Norliqva, Tadliq |
| Regeneron Healthcare Solutions, INC. | $739.74 | 2019-2025 | Dupixent |
| Avanir Pharmaceuticals, INC. | $683.90 | 2019-2021 | |
| Shield Therapeutics INC | $682.17 | 2023-2025 | Accrufer |
| Sumitomo Pharma America, INC. | $638.47 | 2023-2025 | Gemtesa |
| Qiagen, LLC | $631.87 | 2019-2021 | |
| Pfizer INC. | $628.25 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $558.89 | 2021-2025 | |
| Nestle Healthcare Nutrition INC. | $529.68 | 2020-2023 | |
| Horizon Therapeutics Plc | $526.28 | 2019-2022 | |
| Exact Sciences Corporation | $486.16 | 2023-2025 | Cologuard Collection Kit |
| Kowa Pharmaceuticals America, INC. | $478.95 | 2019-2025 | Zoryve, Seglentis |
| Xeris Pharmaceuticals, INC. | $402.61 | 2020-2025 | Recorlev, Keveyis, Gvoke Hypopen |
| Endo Pharmaceuticals INC. | $369.87 | 2019-2023 | Nascobal |
| Aimmune Therapeutics, INC. | $367.82 | 2024-2025 | Zenpep |
| Mylan Specialty L.P. | $367.53 | 2019-2024 | Yupelri |
| Janssen Pharmaceuticals, INC | $349.58 | 2019-2022 | |
| Grifols USA, LLC | $340.92 | 2019-2021 | |
| Valeritas, INC. | $328.14 | 2019 | |
| Viatris Specialty LLC | $326.07 | 2025 | Yupelri |
| Paratek Pharmaceuticals, INC. | $321.61 | 2020-2023 | Nuzyra |
| Arbor Pharmaceuticals, INC. | $285.93 | 2019-2022 | |
| Actelion Pharmaceuticals US, INC. | $280.66 | 2021-2022 | |
| Vanda Pharmaceuticals INC. | $259.10 | 2024-2025 | Fanapt, Hetlioz |
| Idorsia Pharmaceuticals US INC | $257.96 | 2022-2024 | Quviviq |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $257.00 | 2022-2025 | Caplyta |
| Mannkind Corporation | $224.38 | 2020-2021 | |
| Biogen, INC. | $221.01 | 2020-2021 | |
| Alkermes, INC. | $195.95 | 2022-2025 | Aristada, Lybalvi |
| Gilead Sciences, INC. | $181.71 | 2019-2025 | |
| Cequr Corporation | $180.31 | 2022-2025 | Cequr Simplicity |
| Phathom Pharmaceuticals, INC. | $176.42 | 2024-2025 | Voquezna |
| Takeda Pharmaceuticals U.S.A., INC. | $173.92 | 2021-2025 | Trintellix |
| Harmony Biosciences LLC | $164.22 | 2025 | |
| Boston Scientific Corporation | $134.97 | 2019-2023 | Rezum Generator |
| Insulet Corporation | $125.11 | 2019 | |
| Coloplast Corp | $125.00 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $123.24 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $120.34 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $117.59 | 2023-2024 | Inpefa |
| Redhill Biopharma INC. | $105.45 | 2020-2022 | |
| Ars Pharmaceuticals Operations, INC. | $89.69 | 2025 | Neffy |
| Azurity Pharmaceuticals, INC. | $84.38 | 2023-2025 | Adthyza, Alvesco, Horizant |
| Orexo US, INC. | $83.24 | 2021 | |
| Halozyme INC | $79.68 | 2023 | |
| Corium, LLC | $66.05 | 2023 | Adlarity |
| Verity Pharmaceuticals INC. | $65.51 | 2024-2025 | Tlando |
| Eisai INC. | $63.60 | 2020 | |
| Dexcom, INC. | $63.44 | 2020 | |
| Almatica Pharma LLC | $61.69 | 2021 | |
| Amneal Pharmaceuticals LLC | $59.19 | 2022-2025 | Unithroid, Crexont |
| Acerus Pharmaceuticals Corporation | $46.59 | 2022 | |
| Zealand Pharma US, INC. | $38.56 | 2020-2021 | |
| Bausch Health US, LLC | $37.86 | 2025 | Aplenzin |
| E.R. Squibb & Sons, L.L.C. | $34.63 | 2019-2025 | Camzyos |
| Ibsa Pharma INC. | $33.30 | 2019-2021 | |
| Alfasigma USA, INC. | $25.62 | 2020 | |
| Verona Pharma, INC. | $25.54 | 2025 | Ohtuvayre |
| Collegium Pharmaceutical, INC. | $23.95 | 2022 | |
| Genentech USA, INC. | $21.39 | 2020 | |
| Verrica Pharmaceuticals INC. | $21.01 | 2023 | Ycanth |
| Scilex Pharmaceuticals INC. | $19.90 | 2021 | |
| Urovant Sciences INC | $19.72 | 2021 | |
| Evoke Pharma, INC. | $17.11 | 2022 | |
| Corcept Therapeutics | $16.50 | 2024 | Korlym |
| Ipsen Biopharmaceuticals, INC | $15.73 | 2019 | |
| Phadia US INC. | $15.59 | 2023 | Immunocap |
| Neurocrine Biosciences, INC. | $14.83 | 2022 | |
| Currax Pharmaceuticals LLC | $14.59 | 2025 | Contrave |
| Shionogi INC | $14.22 | 2019 | |
| Global Blood Therapeutics, INC. | $11.85 | 2020 |
Drugs and devices associated with these payments
Qulipta $2,521Ubrelvy $2,478Dupixent $2,301Linzess $1,654Rexulti $1,560Tezspire $1,516Farxiga $1,288Rybelsus $1,253Ozempic $1,234Creon $1,194Trelegy Ellipta $1,028Xifaxan $971Vraylar $963Repatha $919Auvelity $863Otezla $771Veozah $741Jardiance $720Evenity $706Airsupra $700Accrufer $682Gemtesa $638Yupelri $630Nexletol $618Zenpep $616Ibsrela $616Breztri $604Aristada $593Arexvy $522Prolia $520Freestyle Libre 3 $511Cologuard Collection Kit $486Verquvo $453Carospir $436Mounjaro $435Xyosted $345Fasenra $343Botox $330Shingrix $298Recorlev $289Lybalvi $260Fanapt $259Wegovy $257Trulance $252Injectafer $245Dificid $221Nucala $218Quviviq $218Kerendia $218Lokelma $211Abilify Maintena $208Norliqva $194Hetlioz $189Caplyta $188Voquezna $176Entresto $172Zepbound $163Tlando $156Relistor $150Nurtec Odt $140Emgality $134Viberzi $128Belsomra $122Stiolto Respimat $121Tadliq $119Rezum Generator $115Trintellix $115Zavzpret $113Myrbetriq $112Soliqua 100/33 $106Atorvaliq $101Liqrev $101Symbravo $99.88Nocdurna $90.47Neffy $89.69Keveyis $82.83Vyepti $80.18Cosentyx $76.78Cequr Simplicity $76.54Adlarity $66.05Inpefa $65.88Reyvow $64.30Wakix $64.23Zoryve $62.58Eliquis $61.86Steglatro $59.52Spiriva Respimat $58.48Comirnaty $51.82Cycloset $49.53Kisunla $44.53Synthroid $44.17Nuzyra $42.25Tzield $39.02Aplenzin $37.86Abilify Asimtufii $36.15Krystexxa $32.46Horizant $31.15Paxlovid $27.00Ohtuvayre $25.54Prevnar 20 $24.82
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Khalil listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.